Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
JAMA. 2011 Dec 14;306(22):2487-94. doi: 10.1001/jama.2011.1790.
Percutaneous coronary interventions are performed at centers without onsite surgery, despite current guidelines discouraging this.
To assess literature comparing rates of in-hospital mortality and emergency coronary artery bypass grafting surgery at centers with and without on-site surgery.
A systematic search of studies published between January 1990 and May 2010 was conducted using MEDLINE, EMBASE, and Cochrane Review databases.
English-language studies of percutaneous coronary intervention performed at centers with and without on-site surgery providing data on in-hospital mortality and emergency bypass were identified. Two study authors independently reviewed the 1029 articles originally identified and selected 40 for analysis.
Study title, time period, indication for angioplasty, and outcomes were extracted manually from all selected studies, and quality of each study was assessed using the strengthening the reporting of observational studies in epidemiology (STROBE) checklist.
High-quality studies of percutaneous coronary interventions performed at centers with and without on-site surgery were included. Pooled-effect estimates were calculated with random-effects models. Analyses of primary percutaneous coronary intervention for ST-segment elevation myocardial infarction of 124,074 patients demonstrated no increase in in-hospital mortality (no on-site surgery vs on-site surgery: observed risk, 4.6% vs 7.2%; odds ratio [OR], 0.96; 95% CI, 0.88-1.05; I(2) = 0%) or emergency bypass (observed risk, 0.22% vs 1.03%; OR, 0.53; 95% CI, 0.35-0.79; I(2) = 20%) at centers without on-site surgery. For nonprimary percutaneous coronary interventions (elective and urgent, n = 914,288), the rates of in-hospital mortality (observed risk, 1.4% vs 2.1%; OR, 1.15; 95% CI, 0.93-1.41; I(2) = 46%) and emergency bypass (observed risk, 0.17% vs 0.29%; OR, 1.21; 95% CI, 0.52-2.85; I(2) = 5%) were not significantly different at centers without or with on-site surgery.
Percutaneous coronary interventions performed at centers without on-site surgery, compared with centers with on-site surgery, were not associated with a higher incidence of in-hospital mortality or emergency bypass surgery.
尽管目前的指南不鼓励这样做,但经皮冠状动脉介入治疗仍在没有现场手术的中心进行。
评估比较有和无现场手术中心行经皮冠状动脉介入治疗的住院死亡率和紧急冠状动脉旁路移植术的文献。
使用 MEDLINE、EMBASE 和 Cochrane 评价数据库,对 1990 年 1 月至 2010 年 5 月期间发表的研究进行了系统搜索。
确定了在有和无现场手术中心进行的经皮冠状动脉介入治疗的英语研究,提供了住院死亡率和紧急旁路的相关数据。两位研究作者独立地审查了最初确定的 1029 篇文章,并选择了 40 篇进行分析。
手动从所有入选的研究中提取研究标题、时间范围、血管成形术适应证和结局,并使用流行病学中观察性研究的强化报告标准(STROBE)检查表评估每项研究的质量。
纳入了有和无现场手术中心行经皮冠状动脉介入治疗的高质量研究。采用随机效应模型计算汇总效应估计值。对 124074 例 ST 段抬高型心肌梗死患者的直接经皮冠状动脉介入治疗的分析表明,在无现场手术中心住院死亡率(无现场手术 vs 有现场手术:观察风险 4.6% vs 7.2%;比值比[OR],0.96;95%置信区间[CI],0.88-1.05;I²=0%)或紧急旁路(观察风险 0.22% vs 1.03%;OR,0.53;95%CI,0.35-0.79;I²=20%)并无增加。对于非原发性经皮冠状动脉介入治疗(择期和紧急,n=914288),住院死亡率(观察风险 1.4% vs 2.1%;OR,1.15;95%CI,0.93-1.41;I²=46%)和紧急旁路(观察风险 0.17% vs 0.29%;OR,1.21;95%CI,0.52-2.85;I²=5%)在无现场手术或有现场手术中心并无显著差异。
与有现场手术中心相比,无现场手术中心行经皮冠状动脉介入治疗与住院死亡率或紧急旁路手术发生率的增加无关。